ロード中...
Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
Alemtuzumab is a humanized monoclonal antibody directed against CD52 to deplete circulating T and B lymphocytes; lymphocyte depletion is followed by a distinctive pattern of T- and B-cell repopulation, changing the balance of the immune system. This review reports the efficacy and safety findings of...
保存先:
| 出版年: | Mult Scler |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361497/ https://ncbi.nlm.nih.gov/pubmed/25344374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458514549398 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|